143 related articles for article (PubMed ID: 38282119)
1. Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD
Cheng J; Zhang J; He S; Li M; Dong G; Sheng C
Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202315997. PubMed ID: 38282119
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead.
Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C
Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332
[TBL] [Abstract][Full Text] [Related]
3. Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT.
Cheng J; He S; Xu J; Huang M; Dong G; Sheng C
J Med Chem; 2022 Dec; 65(23):15725-15737. PubMed ID: 36442664
[TBL] [Abstract][Full Text] [Related]
4. Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation.
Zhu X; Liu H; Chen L; Wu C; Liu X; Cang Y; Jiang B; Yang X; Fan G
Cell Chem Biol; 2022 Nov; 29(11):1616-1629.e12. PubMed ID: 36323324
[TBL] [Abstract][Full Text] [Related]
5. Restoring NAD
Katayoshi T; Nakajo T; Tsuji-Naito K
J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
7. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
Revollo JR; Grimm AA; Imai S
Curr Opin Gastroenterol; 2007 Mar; 23(2):164-70. PubMed ID: 17268245
[TBL] [Abstract][Full Text] [Related]
8. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
[TBL] [Abstract][Full Text] [Related]
9. NAMPT: A critical driver and therapeutic target for cancer.
Gasparrini M; Audrito V
Int J Biochem Cell Biol; 2022 Apr; 145():106189. PubMed ID: 35219878
[TBL] [Abstract][Full Text] [Related]
10. Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
Zhao Y; Guan YF; Zhou XM; Li GQ; Li ZY; Zhou CC; Wang P; Miao CY
Stroke; 2015 Jul; 46(7):1966-74. PubMed ID: 26060246
[TBL] [Abstract][Full Text] [Related]
11. NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair.
Wang P; Li WL; Liu JM; Miao CY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):474-81. PubMed ID: 26485210
[TBL] [Abstract][Full Text] [Related]
12. Nampt and its potential role in inflammation and type 2 diabetes.
Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer.
Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a Potent Nicotinamide Phosphoribosyltransferase Activator for Improving Aging-associated Dysfunctions.
Yang S; Sun D; Wu Y; Chen S; Guo Y; Li J; Dong G; Sheng C
J Med Chem; 2024 Mar; 67(5):4120-4130. PubMed ID: 38367219
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
Feng D; Xu D; Murakoshi N; Tajiri K; Qin R; Yonebayashi S; Okabe Y; Li S; Yuan Z; Aonuma K; Ieda M
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629939
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide Phosphoribosyltransferase-elevated NAD
Zhang Y; Wang Y; Lu S; Zhong R; Liu Z; Zhao Q; Wang C
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):1003-1018. PubMed ID: 36864250
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases.
Imai S
Curr Pharm Des; 2009; 15(1):20-8. PubMed ID: 19149599
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]